Nebula Genomics

Acquired

Discover what your DNA says about your health and ancestry.

United States · $4.3M raised

Headquarters
Massachusetts
Employees
11–50
Business Model
B2C
Website
nebula.org
Total Funding
$4.3M
Last Round
$4.3M SeedAug 2018
Rounds
1
Acquisition Date
Aug 2021

About

Nebula Genomics offers 30x whole genome sequencing that analyzes 100% of a customer's DNA, providing health and ancestry insights while guaranteeing genomic data privacy. Founded in 2018 by Harvard geneticist George Church, the company was acquired by ProPhase Labs in 2021 for approximately $14.6 million. It serves both individual consumers and academic research institutions.

Summary

Nebula Genomics is a Biotech company based in United States. It has raised $4.3M in total across 1 round, most recently a $4.3M Seed round in Aug 2018. Investors include Khosla Ventures, ARCH Venture Partners and F-Prime Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionAcquisition by ProPhase LabsAug 2021

Sign up to see all 2 rounds

Seed through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nebula Genomics on Indexed.vc
<a href="https://indexed.vc/companies/nebula-genomics"><img src="https://indexed.vc/api/badge/company/nebula-genomics" alt="Nebula Genomics on Indexed.vc" width="260" height="76" /></a>